Long Corridor Asset Management »

Actuate Therapeutics shares owned by Long Corridor Asset Management

Quarter-by-quarter ownership of Actuate Therapeutics shares owned by Long Corridor Asset Management from 13F filings

Historical chart of Long Corridor Asset Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Long Corridor Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Long Corridor Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $931k 125k 7.45